Document is current
Any future updates will be listed below
-
Authors
Riggs, Patricia K.
Chaillon, Antoine
Jiang, Guochun
Letendre, Scott L.
Tang, Yuyang
Taylor, Jeff
Kaytes, Andrew
Smith, Davey M.
Dubé, Karine
Gianella, Sara
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI131385)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI47821)
NIDA (DA055491)
NIDA (DA051915)
- License Information
-
More Information
Article History
Accepted: 29 August 2022
First Online: 19 October 2022
Declarations
:
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
: DS has received consulting fees outside the submitted work from Matrix Biomed; Vx Biosciences, Signant Health, Model Medicines, Kiadis Pharmaceuticals, Bayer Pharmaceuticals, and owns equity in Linear Therapies. SLL received an unrelated grant from Merck & Co. All other authors declare no competing interests.
